News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
736,078 Results
Type
Article (49048)
Company Profile (305)
Press Release (686725)
Multimedia
Podcasts (73)
Webinars (13)
Section
Business (211490)
Career Advice (2110)
Deals (36440)
Drug Delivery (113)
Drug Development (83069)
Employer Resources (175)
FDA (16847)
Job Trends (15664)
News (357747)
Policy (34946)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (6)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (7)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (6)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (6)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (5)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (2)
Academia (2830)
Academic (2)
Accelerated approval (5)
Adcomms (22)
Allergies (85)
Alliances (51586)
ALS (89)
Alzheimer's disease (1429)
Antibody-drug conjugate (ADC) (132)
Approvals (16844)
Artificial intelligence (272)
Autoimmune disease (23)
Automation (16)
Bankruptcy (368)
Best Places to Work (12259)
BIOSECURE Act (20)
Biosimilars (113)
Biotechnology (203)
Bladder cancer (65)
Brain cancer (26)
Breast cancer (280)
Cancer (2198)
Cardiovascular disease (180)
Career advice (1769)
Career pathing (30)
CAR-T (150)
Cell therapy (417)
Cervical cancer (20)
Clinical research (67352)
Collaboration (846)
Compensation (521)
Complete response letters (20)
COVID-19 (2770)
CRISPR (42)
C-suite (241)
Cystic fibrosis (104)
Data (2113)
Decentralized trials (2)
Denatured (27)
Depression (46)
Diabetes (276)
Diagnostics (6700)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (123)
Drug pricing (116)
Drug shortages (26)
Duchenne muscular dystrophy (95)
Earnings (88060)
Editorial (40)
Employer branding (22)
Employer resources (149)
Events (120467)
Executive appointments (736)
FDA (18098)
Featured Employer (53)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (786)
Gene editing (109)
Generative AI (26)
Gene therapy (305)
GLP-1 (753)
Government (4954)
Grass and pollen (5)
Guidances (52)
Healthcare (20296)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (120)
Indications (28)
Infectious disease (2924)
Inflammatory bowel disease (137)
Inflation Reduction Act (11)
Influenza (55)
Intellectual property (92)
Interviews (331)
IPO (16835)
IRA (44)
Job creations (3850)
Job search strategy (1504)
Kidney cancer (10)
Labor market (38)
Layoffs (482)
Leadership (16)
Legal (8463)
Liver cancer (75)
Lung cancer (314)
Lymphoma (146)
Machine learning (6)
Management (60)
Manufacturing (306)
MASH (70)
Medical device (14009)
Medtech (14014)
Mergers & acquisitions (20140)
Metabolic disorders (709)
Multiple sclerosis (80)
NASH (17)
Neurodegenerative disease (92)
Neuropsychiatric disorders (28)
Neuroscience (1968)
NextGen: Class of 2025 (7115)
Non-profit (4909)
Northern California (2624)
Now hiring (39)
Obesity (384)
Opinion (230)
Ovarian cancer (74)
Pain (86)
Pancreatic cancer (83)
Parkinson's disease (151)
Partnered (21)
Patents (230)
Patient recruitment (106)
Peanut (47)
People (59794)
Pharmaceutical (74)
Pharmacy benefit managers (20)
Phase I (21044)
Phase II (29522)
Phase III (22034)
Pipeline (1149)
Policy (148)
Postmarket research (2760)
Preclinical (8907)
Press Release (71)
Prostate cancer (102)
Psychedelics (34)
Radiopharmaceuticals (257)
Rare diseases (395)
Real estate (6192)
Recruiting (66)
Regulatory (23646)
Reports (46)
Research institute (2530)
Resumes & cover letters (361)
Rett syndrome (4)
RNA editing (4)
RSV (46)
Schizophrenia (69)
Series A (137)
Series B (89)
Service/supplier (13)
Sickle cell disease (57)
Southern California (2282)
Special edition (17)
Spinal muscular atrophy (153)
Sponsored (30)
Startups (3800)
State (2)
Stomach cancer (15)
Supply chain (72)
Tariffs (34)
The Weekly (44)
United States (23190)
Vaccines (749)
Venture capitalists (41)
Weight loss (254)
Women's health (39)
Worklife (16)
Date
Today (162)
Last 7 days (612)
Last 30 days (2518)
Last 365 days (33967)
2025 (10187)
2024 (36410)
2023 (41347)
2022 (52602)
2021 (57322)
2020 (56298)
2019 (49437)
2018 (37431)
2017 (33561)
2016 (33633)
2015 (39690)
2014 (33357)
2013 (28362)
2012 (30555)
2011 (31217)
2010 (29446)
Location
Africa (839)
Alabama (56)
Alaska (7)
Arizona (248)
Arkansas (14)
Asia (40502)
Australia (6741)
California (6045)
Canada (1987)
China (514)
Colorado (268)
Connecticut (283)
Delaware (141)
Europe (88254)
Florida (891)
Georgia (214)
Hawaii (1)
Idaho (63)
Illinois (556)
India (26)
Indiana (317)
Iowa (10)
Japan (160)
Kansas (105)
Kentucky (25)
Louisiana (12)
Maine (70)
Maryland (911)
Massachusetts (4570)
Michigan (237)
Minnesota (404)
Mississippi (2)
Missouri (85)
Montana (29)
Nebraska (25)
Nevada (61)
New Hampshire (67)
New Jersey (1734)
New Mexico (28)
New York (1731)
North Carolina (1025)
North Dakota (7)
Northern California (2624)
Ohio (208)
Oklahoma (15)
Oregon (36)
Pennsylvania (1348)
Puerto Rico (11)
Rhode Island (32)
South America (1213)
South Carolina (23)
South Dakota (1)
Southern California (2282)
Tennessee (102)
Texas (899)
Utah (183)
Virginia (148)
Washington D.C. (65)
Washington State (563)
West Virginia (3)
Wisconsin (61)
736,078 Results for "lucira health inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Lucira Health Launches Lucira Connect, a Free Test-to-Treat Telehealth Service for Covid-19 or Flu in Canada
Lucira Health, Inc. announced the Canadian launch of Lucira Connect, a new virtual care program that allows Lucira test users the ability to test, learn about treatment options, access a telehealth consultation, and if appropriate, receive a prescription all from home for only the price of the test, excluding prescription costs.
January 4, 2023
·
6 min read
Biotech Bay
Lucira Health Announces National Launch of Lucira Connect Test-to-Treat Service
Lucira Health, Inc. announced the launch of Lucira Connect, a new virtual care program that allows Lucira test users the ability to test, learn about treatment options, access a telehealth consultation, and if appropriate, receive a prescription all from home for only the $29 price of the test, excluding prescription costs.
November 17, 2022
·
5 min read
Press Releases
Oragenics, Inc. Announces Health and Disability Ethics Committee Submission for Phase IIa Concussion Trial
April 10, 2025
·
3 min read
IN PARTNERSHIP WITH DIA
Economic Challenges, Strategic Investments: Reshaping the Women’s Health Landscape
In this episode presented by DIA, BioSpace’s head of insights Lori Ellis discusses how collaboration and investment shape the the future of women’s health with Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives at the National Academy of Medicine.
April 24, 2025
·
1 min read
·
Lori Ellis
Business
Lucira Health to Announce Third Quarter 2022 Financial Results
Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease tests, and a digital health platform that will connect patients with providers, today announced that the company will report third quarter 2022 financial results on, Monday, November 14th, 2022.
November 1, 2022
·
1 min read
Business
“Perfect Patient” Industry Burdens; Exits and Investment in Women’s Health
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis and Miruna Sasu, CEO of COTA, discuss the challenges of inclusion and exclusion criteria of clinical trial patients, and reflect on current investment approaches around women’s health.
March 13, 2025
·
1 min read
·
Lori Ellis
Press Releases
Tivic Health Systems, Inc. Announces Reverse Stock Split
March 5, 2025
·
6 min read
Press Releases
FOXO TECHNOLOGIES INC. PROVIDES UPDATE ON ITS BEHAVIORAL HEALTH SUBSIDIARY, MYRTLE RECOVERY CENTERS, INC.
March 12, 2025
·
3 min read
Deals
Lucira Health to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
Lucira Health, Inc., a medical technology company, announced that it has filed for protection under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware.
February 22, 2023
·
7 min read
Venture capitalists
Bausch Health Tussles With Activist Investor Carl Icahn After Popping Poison Pill
Bausch Health has launched a shareholder rights plan—also known as a poison pill defense—designed to prevent any one entity from taking control of the company to the detriment of other shareholders.
April 23, 2025
·
1 min read
·
Tristan Manalac
1 of 73,608
Next